This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
How does Brainsway’s TMS treatment compare with ECT?
While ECT entails electrically induced seizures, Brainsway* Deep TMS therapy stimulates brain regions using brief magnetic pulses at an amplitude similar to that used in MRI systems. ECT requires anesthesia and may entail severe side effects, including memory loss, while Deep TMS therapy does not involve anesthesia, has no effects on memory, and is generally well-tolerated.